Market closedNon-fractional
Recursion Pharmaceuticals/RXRX
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Recursion Pharmaceuticals
Recursion Pharmaceuticals Inc is a clinical-stage biotechnology company. It is decoding biology by integrating technological innovations across biology, chemistry, automation, data science, and engineering, with the goal of radically improving the lives of patients and industrializing drug discovery.
Ticker
RXRX
Sector
Healthcare
Trading on
NASDAQ
Industry
Biotechnology
Headquarters
Salt Lake City, United States
Employees
500
Website
www.recursion.com
RXRX Metrics
BasicAdvanced
$2.2B
Market cap
-
P/E ratio
-$1.62
EPS
0.85
Beta
-
Dividend rate
Price and volume
Market cap
$2.2B
Beta
0.85
Financial strength
Current ratio
4.648
Quick ratio
4.044
Long term debt to equity
11.182
Total debt to equity
12.707
Interest coverage (TTM)
-3,853.02%
Management effectiveness
Return on assets (TTM)
-39.82%
Return on equity (TTM)
-85.19%
Valuation
Price to revenue (TTM)
38.122
Price to book
4.77
Price to tangible book (TTM)
6.05
Price to free cash flow (TTM)
-5.331
Growth
Revenue change (TTM)
-0.88%
Earnings per share change (TTM)
17.50%
3-year revenue growth (CAGR)
92.67%
3-year earnings per share growth (CAGR)
-28.83%
What the Analysts think about RXRX
Analyst Ratings
Majority rating from 7 analysts.
RXRX Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$14M
26.85%
Net income
-$91M
-1.72%
Profit margin
-666.42%
-22.53%
RXRX Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.38
-$0.43
-$0.42
-$0.39
-
Expected
-$0.37
-$0.39
-$0.45
-$0.42
-$0.41
Surprise
1.53%
11.69%
-6.41%
-7.87%
-
RXRX News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Recursion Pharmaceuticals stock?
Recursion Pharmaceuticals (RXRX) has a market cap of $2.2B as of July 27, 2024.
What is the P/E ratio for Recursion Pharmaceuticals stock?
The price to earnings (P/E) ratio for Recursion Pharmaceuticals (RXRX) stock is 0 as of July 27, 2024.
Does Recursion Pharmaceuticals stock pay dividends?
No, Recursion Pharmaceuticals (RXRX) stock does not pay dividends to its shareholders as of July 27, 2024.
When is the next Recursion Pharmaceuticals dividend payment date?
Recursion Pharmaceuticals (RXRX) stock does not pay dividends to its shareholders.
What is the beta indicator for Recursion Pharmaceuticals?
Recursion Pharmaceuticals (RXRX) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.
Buy or sell Recursion Pharmaceuticals stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.